clinical herd health farm management antimicrobial resistance campylobacter coli finishing pig farms switzerland pubmed ncbi abstract world-wide increase antimicrobial resistance micro-organisms complicates medical treatment infected humans risk-factor analysis prevalence antimicrobial resistant campylobacter coli num swiss pig finishing farms november num faecal samples farm collected floor pens holding finishing pigs shortly slaughter samples pooled cultured campylobacter species isolated campylobacter strains tested resistance selected antimicrobials additionally information herd health management aspects study data quality history antimicrobial farms poor non-antimicrobial risk factors analysed statistical analyses performed resistance ciprofloxacin erythromycin streptomycin tetracycline multiple resistance defined resistance antimicrobials risk factors outcomes--corrected dependency samples herd level--were analysed generalised estimation-equation models prevalence antimicrobial resistance campylobacter isolates ciprofloxacin num erythromycin num streptomycin num tetracycline num multiple resistance num important risk factors contributing prevalence resistant strains shortened tails lameness skin lesions feed whey ad libitum feeding multiple resistance farms partially all-in-all-out system num continuous-flow system num compared strict all-in-all-out animal-flow presence lameness num ill-thrift num scratches shoulder num herd increased odds multiple resistance study showed finishing farms maintained good herd health status optimal farm management prevalence antimicrobial resistance favourable 
